Status:
ACTIVE_NOT_RECRUITING
Evaluation of Cascade Screening for Elevated Lipoprotein(a)
Lead Sponsor:
Karolinska Institutet
Conditions:
Cardiovascular Diseases
Dyslipidemias
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the current project is to evaluate the penetrance of elevated plasma Lp(a) levels in patients with atherosclerotic coronary artery disease to their first- and second-degree biological relat...
Detailed Description
An elevated plasma level of lipoprotein(a) \[Lp(a)\] is an independent and causative risk factor for atherosclerotic cardiovascular disease. The Lp(a) plasma level is predominantly genetically determi...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- participation in the clinical health care development project
- established atherosclerotic coronary artery disease
- Exclusion Criteria:
- diagnosis of familial hypercholesterolemia
- chronic kidney disease stadium ≥4
Exclusion
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 16 2025
Estimated Enrollment :
1950 Patients enrolled
Trial Details
Trial ID
NCT06157983
Start Date
December 1 2023
End Date
June 16 2025
Last Update
June 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska university hospital
Stockholm, Stockholm County, Sweden, SE-14186